Codes / ICD10CM / C85.06

C85.06 Lymphosarcoma, intrapelvic lymph nodes

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lymphosarcoma, intrapelvic lymph nodes
  • C85.06

Summary

Lymphosarcoma, intrapelvic lymph nodes, is a type of non-Hodgkin lymphoma (NHL) that specifically involves the lymph nodes within the pelvic region. This condition affects the lymphatic system, part of the immune system, and involves abnormal growth of lymphoid cells. The term "lymphosarcoma" is a historical classification now categorized under NHL.

Causes

The exact cause of lymphosarcoma in intrapelvic lymph nodes is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

  • Advanced age (more common in older adults)
  • Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
  • Certain infections (e.g., Epstein-Barr virus, H. pylori)
  • Exposure to chemicals (e.g., pesticides, herbicides)
  • Family history of lymphoma
  • Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

  • Swollen lymph nodes in the pelvic area
  • Pelvic pain or discomfort
  • Abdominal swelling or fullness
  • Difficulty urinating or changes in bowel habits
  • Fever, night sweats, or unexplained weight loss
  • Fatigue or weakness

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI scans), and biopsy of the affected lymph nodes. Blood tests may also be performed to assess overall health and detect abnormalities. A pathologist examines the biopsy sample to confirm the presence of lymphoma and determine its subtype.

Treatment Options

Treatment depends on the stage and aggressiveness of the lymphoma and may include chemotherapy, radiation therapy, immunotherapy, or targeted therapy. In some cases, a combination of these approaches is used. Treatment plans are tailored to the individual patient and may involve collaboration between oncologists, radiologists, and other specialists.

Prognosis and Follow-Up

Prognosis varies based on factors such as the lymphoma subtype, stage at diagnosis, and patient response to treatment. Regular follow-up appointments are essential to monitor for recurrence or progression. Follow-up may include physical exams, imaging, and blood tests to assess treatment effectiveness and detect any changes early.

Complications

Potential complications include obstruction of nearby organs (e.g., bladder or intestines), pain, infection, or spread of the lymphoma to other parts of the body. Treatment side effects, such as nausea, fatigue, or immune suppression, may also occur and require management.

Lifestyle & Prevention

While specific prevention strategies for lymphosarcoma are limited, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive chemical exposure) may support overall health. Patients should follow their healthcare provider’s recommendations for lifestyle modifications.

When to Seek Professional Help

Seek medical attention if you experience persistent pelvic pain, unexplained swelling, or symptoms like fever, night sweats, or weight loss. Early evaluation is important for accurate diagnosis and timely treatment.

Tips for Medical Coders

When coding for C85.06, ensure the documentation specifies "intrapelvic lymph nodes" to confirm the correct anatomical site. Verify that the diagnosis aligns with the clinical findings and that no more specific lymphoma codes apply. Document any relevant details, such as biopsy results or imaging, to support code assignment.

Book a walkthrough

C85.06 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.